Atlanta Braves (NASDAQ:BATRA – Get Free Report) will announce its earnings results before the market opens on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.35 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
Atlanta Braves (NASDAQ:BATRA – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The financial services provider reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.32 by $0.14. Atlanta Braves had a negative return on equity of 11.36% and a negative net margin of 9.18%. The company had revenue of $282.88 million for the quarter, compared to the consensus estimate of $288.20 million. During the same quarter in the prior year, the business posted ($0.55) EPS. On average, analysts expect Atlanta Braves to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Atlanta Braves Stock Up 0.7 %
Shares of Atlanta Braves stock opened at $42.96 on Tuesday. Atlanta Braves has a 12 month low of $36.78 and a 12 month high of $46.65. The business has a fifty day simple moving average of $43.25 and a 200 day simple moving average of $42.91. The company has a quick ratio of 0.64, a current ratio of 0.64 and a debt-to-equity ratio of 1.08. The stock has a market cap of $2.66 billion, a PE ratio of -43.39 and a beta of 0.85.
About Atlanta Braves
Atlanta Braves Holdings, Inc owns and operates the Atlanta Braves Major league baseball club. It also operates mixed-use development project, including retail, office, hotel, and entertainment projects. The company was incorporated in 2022 and is based in Englewood, Colorado.
Featured Stories
- Five stocks we like better than Atlanta Braves
- 3 Small Caps With Big Return Potential
- Intel: Is Now the Time to Be Brave?Â
- What Are the U.K. Market Holidays? How to Invest and Trade
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What does consumer price index measure?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Atlanta Braves Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlanta Braves and related companies with MarketBeat.com's FREE daily email newsletter.